VolitionRX Limited (VNRX)
(Delayed Data from AMEX)
$0.88 USD
+0.12 (16.21%)
Updated Oct 4, 2024 03:59 PM ET
After-Market: $0.88 0.00 (-0.34%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
VNRX 0.88 +0.12(16.21%)
Will VNRX be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for VNRX based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for VNRX
VolitionRx assumed with a Buy at EF Hutton
VolitionRX Ltd (VNRX) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
Benchmark Co. Remains a Hold on VolitionRX (VNRX)
VolitionRx Limited (VNRX) Q2 2024 Earnings Call Transcript
VolitionRX reports Q2 results